Key figures
> 20.000
employees worldwide
~130
countries in which the Group’s medicines are distributed
~ 20%
of revenue from brand-name medicines invested in R&D each year
€ 6.9 billion
euros in revenue in 2024/2025
3 therapeutic areas
Oncology, neurology, cardiometabolism & venous diseases
Servier Medical Art

Our commitments
Above all, we believe in our profession!
We are a research-based organisation. We are focused on the future and on useful discoveries.
All our activities are based on three key principles.
